BILIARY TRACT CANCER
Clinical trials for BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat bile duct cancer
Disease control TerminatedThis study tested the safety and effectiveness of a new drug called GEN-001 when given alongside an existing immunotherapy (pembrolizumab) for people with advanced bile duct cancer that had stopped responding to standard treatments. It aimed to find the best dose and see if the c…
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Genome & Company • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Two-Pronged attack tested for tough cancers
Disease control TerminatedThis study tested whether combining two drugs, niraparib and dostarlimab, could help control advanced cancers that had specific genetic problems or were previously sensitive to platinum chemotherapy. It involved 51 adults with various cancers, including bladder, stomach, and kidn…
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Halted trial tests hopeful drug combo for Tough-to-Treat cancer
Disease control TerminatedThis study tested whether adding an experimental drug called CPI-613 to standard chemotherapy could better control advanced bile duct cancer. It involved 75 adults with cancer that couldn't be removed by surgery and who hadn't had prior treatment for advanced disease. The trial w…
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC